Dr. Barry Davis has been elected a fellow of the American Society of Hypertension (ASH). According to ASH, this is a distinction conferred upon individuals who have distinguished themselves through excellence in their professional, scientific and clinical achievements; scholarship, and significant contributions to the society and to the field of hypertension and cardiovascular health. Davis is a professor in the Department of Biostatistics at The University of Texas Health Science Center at Houston (UTHealth) School of Public Health.
[Photo: Dr. Barry Davis]
ASH is the largest organization of hypertension researchers and health care providers in the United States Its mission is to prevent and treat hypertension and its consequences. ASH was established in 1985 to promote the exchange of information among scientists, clinical investigators and health care clinicians involved in the study or management of high blood pressure.
Dr. Davis is a biostatistician, clinical trialist and hypertension researcher, led a landmark study of blood pressure medications, which found that diuretics, or water pills, matched or outperformed higher-priced medications. More than 42,000 people participated in the study called the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). He also played a role in three other landmark studies in hypertension as deputy director of the Coordinating Centers for the Hypertension, Detection and Follow-up Program (HDFP) and the Systolic Hypertension in the Elderly Program (SHEP) and as a member of the Data and Safety Monitoring Board for the Systolic Pressure Intervention Trial (SPRINT).
Dr. Jackson Wright, professor emeritus of medicine at Case Western Reserve University School of Medicine, says about Davis’ honor, “Dr. Davis is an internationally renowned leader in the area of cardiovascular (including hypertension) clinical outcome trials who easily commands the respect of those around him. He is a very effective, always well-prepared presenter, and has been an invited presenter at all the major hypertension and cardiovascular scientific meetings and major academic medical centers in the U.S. and internationally.”
Dr. Davis is the holder of the Guy S. Parcel Chair in Public Health at UTHealth School of Public Health; is director of the Coordinating Center for Clinical Trials at the school; and interim chair of the Department of Biostatistics at the School of Public Health. He earned an MD from the University of California, San Diego and a PhD from Brown University. Davis is a fellow of the American Statistical Association, the American Heart Association, the American College of Preventive Medicine, the Society of Clinical Trials, and the American Association for the Advancement of Science. He is an elected member of the International Statistical Institute and the recipient of the 2004 UTHealth President’s Scholar Award for Research. His research focuses of theory and practice of clinical trials, especially in hypertension.